Many Healthworkers in Delhi & Bihar Unwilling to Take Bharat Biotech's Covaxin Due to Lack of Efficacy Data
New Delhi: India is currently undergoing its first phase of the Coronavirus vaccination drive. According to reports, many beneficiaries have shown unwillingness to take Covaxin jab produced by Bharat Biotech. A higher percentage of healthcare workers are opting for Covishield shot, manufactured by the Serum Institute of India.
A report by Times of India said that Delhi doctors have shown apprehension in taking Covaxin shots due to lack of efficacy data. While Covaxin is currently being administered in six central government-run hospitals in Delhi, private and state-run hospitals are using Covishiled jab for vaccination.